IRCT201508061031N11
Completed
Phase 2
Safety and Efficacy of Allogeneic Mesenchymal Stem cell Transplantation in Tibial Fractures (Closed Diaphyseal) clinical trial phase II
Overview
- Phase
- Phase 2
- Intervention
- Not specified
- Conditions
- Tibial Closed Diaphyseal Fractures.
- Sponsor
- Royan Institute
- Enrollment
- 40
- Status
- Completed
- Last Updated
- 8 years ago
Overview
Brief Summary
No summary available.
Investigators
Eligibility Criteria
Inclusion Criteria
- •Inclusion Criteria:
- •Age 18 to 65 years; The presence of tibial fracture based on X ray; Tibial fracture is limited to diaphysial.
Exclusion Criteria
- •Addiction; Pregnancy; liver or kidney disease; uncontrolled diabetes; heart and lung disease; Immune deficiency.
Outcomes
Primary Outcomes
Not specified
Similar Trials
Not yet recruiting
Not Applicable
The mesenchymal stem cell therapy for Hutchinson-Gilford Progeria syndromeEndocrine, nutritional and metabolic diseasesKCT0008336Inha University Hospital1
Recruiting
Phase 2
Exosome Therapy in StrokeIRCT20141224020427N4Shahid Beheshti University of Medical Sciences5
Completed
Not Applicable
Effects of mesenchymal stem cells therapy in peritoneal dialysis patientsChronic kidney disease.Chronic kidney disease, stage 5IRCT2015052415841N2Vice chancellor for research, Tehran University of Medical Sciences10
Recruiting
Phase 1
Comparison of the efficacy of mesenchymal stem cells condition medium injection and ow level laser in the treatment of alopeciaIRCT20200127046282N27Shahid Beheshti University of Medical Sciences30
Recruiting
Phase 1
Evaluation of the safety and effectiveness of mesenchymal stem cells conditioned medium in the treatment of hair lossHair loss.Nonscarring hair loss, unspecifiedL65.9IRCT20200127046282N13Tehran University of Medical Sciences45